Results 101 to 110 of about 511 (145)
A Comprehensive Narrative Review of Drug Interactions Between Traveler's Diarrhea Medications and Chronic Therapies: Implications for Clinical Practice. [PDF]
B S, Satish Kumar RC, B M, C K KS.
europepmc +1 more source
[Practical guideline for short bowel syndrome]. [PDF]
Dabsch S +9 more
europepmc +1 more source
Machine Learning-Based Transcriptomic Diagnosis of Periodontitis. [PDF]
Cheng Y, Yang H, Mo H, Xu P.
europepmc +1 more source
Efficacy and Safety of Oral Herbal Medicine Combined with Diosmectite for Pediatric Rotavirus Gastroenteritis: A Systematic Review and Meta-Analysis. [PDF]
Cho JH, Kim EJ, Sung HK, Min SY.
europepmc +1 more source
COMPARISON OF THE EFFICACY OF PROBIOTICS WITH RACECADOTRIL IN TREATMENT OF ACUTE GASTROENTERITIS
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 2000
Racecadotril is an oral enkephalinase inhibitor used in the treatment of acute diarrhoea. It prevents the degradation of endogenous opioids (enkephalins), thereby reducing hypersecretion of water and electrolytes into the intestinal lumen. In a randomised double-blind study in 6 adult volunteers with castor oil-induced diarrhoea, racecadotril ...
A J, Matheson, S, Noble
+5 more sources
Racecadotril is an oral enkephalinase inhibitor used in the treatment of acute diarrhoea. It prevents the degradation of endogenous opioids (enkephalins), thereby reducing hypersecretion of water and electrolytes into the intestinal lumen. In a randomised double-blind study in 6 adult volunteers with castor oil-induced diarrhoea, racecadotril ...
A J, Matheson, S, Noble
+5 more sources
An overview of clinical studies with racecadotril in adults
International Journal of Antimicrobial Agents, 2000Since preclinical studies had indicated the potential efficacy and tolerability of racecadotril for the treatment of diarrhoea in man, a series of studies was carried out to assess the clinical effects of racecadotril. These studies were also designed to evaluate whether racecadotril possessed the clinical properties that had been previously identified
J M Lecomte
exaly +3 more sources

